Glycogen synthase kinase-3 beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells

Abstract

Glycogen synthase kinase-3, especially the beta form (GSK-3 beta), plays key roles in oxidative stress-induced neuronal cell death, an important pathogenic mechanism of various neurodegenerative diseases. Although the neuroprotective effects of GSK-3 beta inhibitors have been described, the optimal level of GSK-3 beta inhibition for neuronal cell survival has not yet been determined. We investigated the effect of varying GSK-3 beta activity on the viability of oxidative stress-injured neuronally differentiated PC12 (nPC12) cells and intracellular signals related with the GSK-3 beta and caspase-3 pathways. Compared to the nPC12 control cells treated with only 100 mu M H2O2, treatment of 50-200 nM GSK-3 beta inhibitor II or 25-500 nM GSK-3 beta inhibitor VIII reduced the increased enzyme activity by about 50% and protected the cells against H2O2-induced oxidative stress. The optimal concentration of GSK-3 beta inhibitor II enhanced heat shock transcription factor-1 levels, decreased levels of phosphorylated tau (Ser202) and cytosolic cytochrome c, activated caspase-3, and cleaved poly (ADP-ribose) polymerase. In contrast, higher concentrations of GSK-3 beta inhibitor II (more than 500 nM) induced neuronal cell death and showed opposite effects relative to the above described intracellular signals. These results suggest that optimized inhibitor levels for modulating GSK-3 beta activity may prevent apoptosis induced by oxidative stress associated with neurodegenerative diseases.